Literature DB >> 17703346

Indomethacin-saccharin cocrystal: design, synthesis and preliminary pharmaceutical characterization.

Srinivas Basavoju1, Dan Boström, Sitaram P Velaga.   

Abstract

PURPOSE: To design and prepare cocrystals of indomethacin using crystal engineering approaches, with the ultimate objective of improving the physical properties of indomethacin, especially solubility and dissolution rate.
MATERIALS AND METHODS: Various cocrystal formers, including saccharin, were used in endeavours to obtain indomethacin cocrystals by slow evaporation from a series of solvents. The melting point of crystalline phases was determined. The potential cocrystalline phase was characterized by DSC, IR, Raman and PXRD techniques. The indomethacin-saccharin cocrystal (hereafter IND-SAC cocrystal) structure was determined from single crystal X-ray diffraction data. Pharmaceutically relevant properties such as the dissolution rate and dynamic vapour sorption (DVS) of the IND-SAC cocrystal were evaluated. Solid state and liquid-assisted (solvent-drop) cogrinding methods were also applied to indomethacin and saccharin.
RESULTS: The IND-SAC cocrystals were obtained from ethyl acetate. Physical characterization showed that the IND-SAC cocrystal is unique vis-à-vis thermal, spectroscopic and X-ray diffraction properties. The cocrystals were obtained in a 1:1 ratio with a carboxylic acid and imide dimer synthons. The dissolution rate of IND-SAC cocrystal system was considerably faster than that of the stable indomethacin gamma-form. DVS studies indicated that the cocrystals gained less than 0.05% in weight at 98%RH. IND-SAC cocrystal was also obtained by solid state and liquid-assisted cogrinding methods.
CONCLUSIONS: The IND-SAC cocrystal was formed with a unique and interesting carboxylic acid and imide dimer synthons interconnected by weak N-Hcdots, three dots, centeredO hydrogen bonds. The cocrystals were non-hygroscopic and were associated with a significantly faster dissolution rate than indomethacin (gamma-form).

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17703346     DOI: 10.1007/s11095-007-9394-1

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  19 in total

Review 1.  Amorphous drug delivery systems: molecular aspects, design, and performance.

Authors:  Aditya Mohan Kaushal; Piyush Gupta; Arvind Kumar Bansal
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  2004       Impact factor: 4.889

2.  Reaction crystallization of pharmaceutical molecular complexes.

Authors:  Naír Rodríguez-Hornedo; Sarah J Nehm; Kurt F Seefeldt; Yomaira Pagan-Torres; Christopher J Falkiewicz
Journal:  Mol Pharm       Date:  2006 May-Jun       Impact factor: 4.939

3.  Screening for inclusion compounds and systematic construction of three-component solids by liquid-assisted grinding.

Authors:  Tomislav Friscić; Andrew V Trask; William Jones; W D Samuel Motherwell
Journal:  Angew Chem Int Ed Engl       Date:  2006-11-20       Impact factor: 15.336

4.  Profiling indomethacin impurities using high-performance liquid chromatography and nuclear magnetic resonance.

Authors:  S Hess; U Teubert; J Ortwein; K Eger
Journal:  Eur J Pharm Sci       Date:  2001-12       Impact factor: 4.384

5.  Use of a glutaric acid cocrystal to improve oral bioavailability of a low solubility API.

Authors:  Daniel P McNamara; Scott L Childs; Jennifer Giordano; Anthony Iarriccio; James Cassidy; Manjunath S Shet; Richard Mannion; Ed O'Donnell; Aeri Park
Journal:  Pharm Res       Date:  2006-08       Impact factor: 4.200

6.  Physical properties of solid molecular dispersions of indomethacin with poly(vinylpyrrolidone) and poly(vinylpyrrolidone-co-vinyl-acetate) in relation to indomethacin crystallization.

Authors:  T Matsumoto; G Zografi
Journal:  Pharm Res       Date:  1999-11       Impact factor: 4.200

7.  Cocrystal formation during cogrinding and storage is mediated by amorphous phase.

Authors:  Adivaraha Jayasankar; Anongnat Somwangthanaroj; Zezhi J Shao; Naír Rodríguez-Hornedo
Journal:  Pharm Res       Date:  2006-09-19       Impact factor: 4.200

8.  Crystal engineering of the composition of pharmaceutical phases.

Authors:  R D Bailey Walsh; M W Bradner; a S Fleischman; L A Morales; a B Moulton; N Rodríguez-Hornedo; M J Zaworotko
Journal:  Chem Commun (Camb)       Date:  2003-01-21       Impact factor: 6.222

Review 9.  Pharmaceutical co-crystals.

Authors:  Peddy Vishweshwar; Jennifer A McMahon; Joanna A Bis; Michael J Zaworotko
Journal:  J Pharm Sci       Date:  2006-03       Impact factor: 3.534

10.  Crystal engineering approach to forming cocrystals of amine hydrochlorides with organic acids. Molecular complexes of fluoxetine hydrochloride with benzoic, succinic, and fumaric acids.

Authors:  Scott L Childs; Leonard J Chyall; Jeanette T Dunlap; Valeriya N Smolenskaya; Barbara C Stahly; G Patrick Stahly
Journal:  J Am Chem Soc       Date:  2004-10-20       Impact factor: 15.419

View more
  26 in total

1.  Simultaneously improving the mechanical properties, dissolution performance, and hygroscopicity of ibuprofen and flurbiprofen by cocrystallization with nicotinamide.

Authors:  Shing Fung Chow; Miles Chen; Limin Shi; Albert H L Chow; Changquan Calvin Sun
Journal:  Pharm Res       Date:  2012-02-23       Impact factor: 4.200

2.  Detection of cocrystal formation based on binary phase diagrams using thermal analysis.

Authors:  Hiroyuki Yamashita; Yutaka Hirakura; Masamichi Yuda; Toshio Teramura; Katsuhide Terada
Journal:  Pharm Res       Date:  2012-08-21       Impact factor: 4.200

3.  Formation of itraconazole-succinic acid cocrystals by gas antisolvent cocrystallization.

Authors:  Courtney A Ober; Ram B Gupta
Journal:  AAPS PharmSciTech       Date:  2012-10-09       Impact factor: 3.246

4.  Coformer screening using thermal analysis based on binary phase diagrams.

Authors:  Hiroyuki Yamashita; Yutaka Hirakura; Masamichi Yuda; Katsuhide Terada
Journal:  Pharm Res       Date:  2014-02-13       Impact factor: 4.200

5.  Theophylline cocrystals prepared by spray drying: physicochemical properties and aerosolization performance.

Authors:  Amjad Alhalaweh; Waseem Kaialy; Graham Buckton; Hardyal Gill; Ali Nokhodchi; Sitaram P Velaga
Journal:  AAPS PharmSciTech       Date:  2013-01-08       Impact factor: 3.246

6.  Multicomponent chemical imaging of pharmaceutical solid dosage forms with broadband CARS microscopy.

Authors:  Christopher M Hartshorn; Young Jong Lee; Charles H Camp; Zhen Liu; John Heddleston; Nicole Canfield; Timothy A Rhodes; Angela R Hight Walker; Patrick J Marsac; Marcus T Cicerone
Journal:  Anal Chem       Date:  2013-08-20       Impact factor: 6.986

7.  Synthesis, characterization, and computational study of a new dimethoxy-chalcone.

Authors:  Ricardo R Ternavisk; Ademir J Camargo; Francisco B C Machado; José A F F Rocco; Gilberto L B Aquino; Valter H C Silva; Hamilton B Napolitano
Journal:  J Mol Model       Date:  2014-11-25       Impact factor: 1.810

8.  Co-crystals: a novel approach to modify physicochemical properties of active pharmaceutical ingredients.

Authors:  A V Yadav; A S Shete; A P Dabke; P V Kulkarni; S S Sakhare
Journal:  Indian J Pharm Sci       Date:  2009-07       Impact factor: 0.975

Review 9.  Cocrystals to facilitate delivery of poorly soluble compounds beyond-rule-of-5.

Authors:  Gislaine Kuminek; Fengjuan Cao; Alanny Bahia de Oliveira da Rocha; Simone Gonçalves Cardoso; Naír Rodríguez-Hornedo
Journal:  Adv Drug Deliv Rev       Date:  2016-04-29       Impact factor: 15.470

10.  Using cocrystals to systematically modulate aqueous solubility and melting behavior of an anticancer drug.

Authors:  Christer B Aakeröy; Safiyyah Forbes; John Desper
Journal:  J Am Chem Soc       Date:  2009-12-02       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.